Your Cart ()
cload

GUARANTEED SAFE & SECURE CHECKOUT

Spend $x to Unlock Free Shipping to  

Manufacturing Clinical-Grade Cell and Gene Therapy Products - Paperback

$121.22
Checkout Secure
Only 3 left! .. people are viewing this, and 3 recently purchased it
Order in the next to get it by

Great reasons to buy from us:

  • Image of Changed your mind? Ordered the wrong thing? Simply return your item for a prompt exchange or refund.

    30-Day Money-Back Guarantee

    Changed your mind? Ordered the wrong thing? Simply return your item for a prompt exchange or refund.
  • Image of Enjoy free shipping when you spend over $70

    Free Shipping Over $70

    Enjoy free shipping when you spend over $70
  • Image of SSL Protected Checkout & Strongly Secure for Payments

    Secure Checkout

    SSL Protected Checkout & Strongly Secure for Payments
  • Image of Every order is a priority to us. We handle your order quickly to ensure you get your product fast.

    Fast Handling

    Every order is a priority to us. We handle your order quickly to ensure you get your product fast.

by Mohamed Abou-El-Enein (Author)

Advanced therapy medicinal products (ATMP) represents a new class of medicinal products, which include - amongst others - somatic cell and gene therapies. As the final product is intended for administration into humans, manufacturers of ATMPs are obligated to apply good manufacturing practice (GMP) standards within their processes. Reaching and maintaining such standards is cost intensive and requires sophisticated manufacturing facilities. As a result, academic researchers who are developing these novel therapeutic approaches are facing new technological and financial challenges. In order to bring more commercially accessible therapies to patients and demonstrate efficient manufacturing technologies, we established the clean-room technology assessment technique (CTAT). CTAT comprises several tools to identify and assign a reliable monetary value to the different operational processes. The model also serves as a guideline for optimizing the operation of an academic GMP facility.

Number of Pages: 80
Dimensions: 0.19 x 9 x 6 IN
Publication Date: September 18, 2020
Shipping This item ships to
Delivery Estimated between and . Will usually ship within 1 business day.

Description

by Mohamed Abou-El-Enein (Author)

Advanced therapy medicinal products (ATMP) represents a new class of medicinal products, which include - amongst others - somatic cell and gene therapies. As the final product is intended for administration into humans, manufacturers of ATMPs are obligated to apply good manufacturing practice (GMP) standards within their processes. Reaching and maintaining such standards is cost intensive and requires sophisticated manufacturing facilities. As a result, academic researchers who are developing these novel therapeutic approaches are facing new technological and financial challenges. In order to bring more commercially accessible therapies to patients and demonstrate efficient manufacturing technologies, we established the clean-room technology assessment technique (CTAT). CTAT comprises several tools to identify and assign a reliable monetary value to the different operational processes. The model also serves as a guideline for optimizing the operation of an academic GMP facility.

Number of Pages: 80
Dimensions: 0.19 x 9 x 6 IN
Publication Date: September 18, 2020

Shipping

Shipping This item ships to
Delivery Estimated between and . Will usually ship within 1 business day.

Reviews

Manufacturing Clinical-Grade Cell and Gene Therapy Products - Paperback

Manufacturing Clinical-Grade Cell and Gene Therapy Products - Paperback

$121.22
Manufacturing Clinical-Grade Cell and Gene Therapy Products - Paperback

Manufacturing Clinical-Grade Cell and Gene Therapy Products - Paperback

$121.22
3 visitors right now
3 visitors have this item in their cart right now
3 people have bought this item
3 % of people buy 2 or more

Recently viewed products